ZimVie (ZIMV) Set to Announce Earnings on Wednesday

ZimVie (NASDAQ:ZIMVGet Free Report) will release its earnings data after the market closes on Wednesday, May 8th. ZimVie has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties interested in listening to the company’s conference call can do so using this link.

ZimVie (NASDAQ:ZIMVGet Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.10 EPS for the quarter. The company had revenue of $113.07 million during the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%.

ZimVie Price Performance

Shares of NASDAQ:ZIMV opened at $15.20 on Wednesday. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.32 and a current ratio of 2.78. The business has a 50-day moving average of $16.93 and a two-hundred day moving average of $14.67. ZimVie has a 12 month low of $6.52 and a 12 month high of $20.91.

Wall Street Analyst Weigh In

ZIMV has been the subject of several research analyst reports. Barclays upped their price target on ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research note on Tuesday, March 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of ZimVie in a research report on Thursday, April 11th.

View Our Latest Report on ZIMV

ZimVie Company Profile

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

See Also

Earnings History for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.